Global Antidepressant Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Antidepressant Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Product (Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Serotonin Antagonist and Reuptake Inhibitors, and Others), Depressive Disorder (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, and Others), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Antidepressant Market was valued at USD 22,794.7 million in 2023 and is expected to reach USD 32,916.0 million by 2031 while growing at a CAGR of 4.7% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global antidepressant market growth. Antidepressants are prescription medications used to treat depression, a condition that extends beyond brief feelings of sadness or "blue" moods. Depression is a prevalent and significant medical illness that profoundly impacts mood and overall mental well-being.
The increasing prevalence of depression, along with growing awareness and acceptance, and the expansion of indications, are driving forces behind market growth. However, generic competition and concerns regarding side effects and safety serve as significant obstacles to further market expansion.
Furthermore, the global antidepressant industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Product Analysis
The Global Antidepressant Market is segmented among Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Serotonin Antagonist and Reuptake Inhibitors, and Others, based on Product. In 2023, Selective Serotonin Reuptake Inhibitors accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Depressive Disorder Analysis
The Global Antidepressant Market is segmented among Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, and Others, based on Depressive Disorder. In 2023, Major Depressive Disorder accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Antidepressant Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are Alkermes Plc, AbbVie Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline, Inc., H. Lundbeck A/S, Merck KGAA, Pfizer Inc., Teva Pharmaceutical Industries Ltd. (Actavis Generics), Takeda Pharmaceutical Limited Company.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Antidepressant Market Dynamics
Drivers
Restraints
Opportunity
4. Global Antidepressant Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Antidepressant Market Segmentation, By Product
Global Antidepressant Market Share Analysis, By Product
Global Antidepressant Market Growth Analysis, By Product
Global Antidepressant Market Trends, By Product
o Tricyclic Antidepressants
o Selective Serotonin Reuptake Inhibitors
o Serotonin Norepinephrine Reuptake Inhibitors
o Monoamine Oxidase Inhibitors
o Serotonin Antagonist
o Reuptake Inhibitors
o Others
6. Global Antidepressant Market Segmentation, By Depressive Disorder
Global Antidepressant Market Share Analysis, By Depressive Disorder
Global Antidepressant Market Growth Analysis, By Depressive Disorder
Global Antidepressant Market Trends, By Depressive Disorder
o Major Depressive Disorder
o Obsessive-Compulsive Disorder
o Generalized Anxiety Disorder
o Panic Disorder
o Others
7. Global Antidepressant Market Segmentation, By Region
Global Antidepressant Market Share Analysis, By Region
Global Antidepressant Market Growth Analysis, By Region
Global Antidepressant Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
8. Competitive Landscape
Alkermes Plc.*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
AbbVie Inc.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline, Inc.
H. Lundbeck A/S
Merck KGAA
Pfizer Inc.
Teva Pharmaceutical Industries Ltd. (Actavis Generics)
Takeda Pharmaceutical Limited Company
*Similar analysis will be provided for each company listed above.
